Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
PPD, the US-based CRO, opened a central laboratory in...
Hua Medicine of Shanghai reported that its lead program,...
Guangzhou MaxiNovel Pharma has been granted Orphan Drug...
Suzhou Alphamab was granted CFDA approval of an IND for...
Alphamab Oncology of Suzhou has started a Phase I...
The Director of the US FDA's Oncology Center of...
Deals and Financings
• Cytovant Sciences of China...
Jiangsu Hengrui Medicine entered a $165 million agreement...
Harbour BioMed, a Suzhou-Shanghai biopharma, reported...
Deals and Financings
• CANbridge Pharma, a Beijing...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China